Clinical Trial Update: A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis [Phase 1]

View source ↗

Summary

A completed Phase 1 trial comparing diclofenac sodium 3% gel with Solaraze 3% gel for actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Diclofenac Sodium Gel 3% (diclofenac sodium gel 3%)
• Solaraze Gel 3% (diclofenac sodium)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Actinic Keratosis | Phase 1 | Status: COMPLETED